ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK
  • 0.0 (0)
  • Life Sciences

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

  1. 1d ago

    Unmet needs in paediatric diabetes – the potential role of inhaled insulin

    Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populations In this final episode, we dive into: Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth. The INHALE-1 Study: A deep dive into the randomized controlled trial data of 230 youth, highlighting efficacy, per-protocol non-inferiority, less weight gain, and superior treatment satisfaction among kids and parents. Safety Profile: Analyzing forced expiratory volume (FEV1) data showing an excellent safety signal with no differences in pulmonary function or severe hypoglycemic events. Practical Toolkit Use Cases: How the unique pharmacokinetic profile of inhaled insulin provides unmatched benefits for covering adrenaline-rush highs and avoiding hypoglycemia tail effects during sports and exercise. Dosing Guidelines: Overcoming the practical "paradigm shift" of converting injected units to inhaled units and managing dosing effectively. Future Horizons: Anticipating the "INHALE FIRST" study investigating early onboarding for newly diagnosed patients and introducing a new two-unit inhaled insulin cartridge. About ATTD Diabetes Talks: A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation. Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/ Subscribe to the podcast for more updates on advancing diabetes care. #DiabetesManagement #PediatricEndocrinology #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Type1Diabetes Chapters: 00:00 Intro and Unique Challenges in Pediatric Diabetes Management 02:38 The INHALE-1 Study: Efficacy, Satisfaction, and Weight Findings 06:27 Safety Signals, Pulmonary Function, and Adherence Challenges 10:18 Practical Toolkit Use Cases: Managing Sports and Exercise 12:48 Dosing Conversions and Practical Patient Selection Guidelines 15:02 Off-Label Integration with Automated Insulin Delivery (AID) Systems 20:14 Caregiver & School Nurse Roles and Managing Safety Concerns 22:00 Research Gaps, The INHALE FIRST Trial, and Wrap Up

    Unmet needs in paediatric diabetes – the potential role of inhaled insulin

  2. Aug 18

    Use of inhaled insulin with automated insulin delivery (AID) systems

    Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems. In this episode, we dive into: The potential of combining inhaled insulin with current AID technologies. Theoretical advantages, including postprandial management. Current evidence, clinical considerations, and existing evidence gaps. Practical insights for clinicians on patient education and system integration. About ATTD Diabetes Talks: A podcast series dedicated to providing healthcare professionals with the latest knowledge and best practices in diabetes management, supported by MannKind Corporation. Find more resources on the ATTD Education Portal: https://unlok-education.com/attd/ Subscribe to the podcast for more updates on advancing diabetes care. #DiabetesManagement #AIDSystems #InhaledInsulin #ATTD #DiabetesCare #MedicalPodcast #Endocrinology Chapters: 00:00 Intro 03:03 How Inhaled Insulin Works 07:30 Real World Dosing Workflow 10:24 Exercise and Safety Upside 15:45 Clinician Education Tips 17:38 Research Gaps and Trials Needed 19:32 Future Potential and Wrap Up

    Use of inhaled insulin with automated insulin delivery (AID) systems

  3. Aug 11

    Overcoming therapeutic inertia with inhaled insulin

    In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation. Key discussion points: Defining therapeutic inertia in the context of insulin initiation. Common clinician and patient-related barriers that contribute to treatment delays. Practical strategies for introducing inhaled insulin to hesitant patients. System-level considerations, including workflow and reimbursement challenges. Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/ Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together. #DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcast Chapters: 00:00 Why Inhaled Insulin Matters 00:34 Show Intro and Guest 01:22 Defining Therapeutic Inertia 02:19 Clinician Barriers to Insulin 03:49 Patient Fears and Hesitation 05:28 How Inhaled Insulin Helps 07:00 Best Fit Patient Scenarios 08:22 Talking to Hesitant Patients 10:39 Workflow and Coverage Hurdles 13:35 PFT Testing and Side Effects 14:47 Future Role and Wrap Up

    Overcoming therapeutic inertia with inhaled insulin

  4. Aug 4

    Practical implementation of inhaled insulin in clinical practice

    In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch. They discuss: Where inhaled insulin fits today within the overall insulin therapy landscape The best candidates for inhaled insulin in routine clinical practice Key clinical factors to guide decision-making Practical first steps to initiating inhaled insulin Approaches to titration Monitoring strategies, particularly regarding pulmonary safety and glycemic outcomes Shared decision-making and engaging patients Dr Irl Hirsch is Professor of Medicine, in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington School of Medicine.  Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    Practical implementation of inhaled insulin in clinical practice

  5. Jul 28

    Addressing Clinicians’ FAQs on Insulin Therapy

    In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy. They discuss: The most common mistakes or misconceptions in basal insulin initiation and management Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations Leveraging technologies to improve insulin adherence and outcomes Managing hypoglycemia concerns and achieving glycemic targets Addressing psychological and behavioral barriers to insulin use in everyday clinical practice Dr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    Addressing Clinicians’ FAQs on Insulin Therapy

  6. Jul 14

    Personalised Approaches for Complex Populations

    In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations. They discuss: Why personalization is particularly important in insulin therapy The patient groups most in need of a tailored approach How comorbidities or frailty influence insulin decision-making Guidelines, flexibility, and local solutions Dr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    Personalised Approaches for Complex Populations

  7. Jun 30

    Overcoming Barriers to Insulin Adherence

    In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients. They discuss: The barriers most misunderstood by clinicians Communication and motivational interviewing with patients Emotional burden and fear of hypoglycemia Practical strategies clinicians can use to support patients more effectively The role of the wider diabetes healthcare team Diana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    Overcoming Barriers to Insulin Adherence

  8. Jun 16

    Preventing & Managing Hypoglycemia

    In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: Why hypoglycemia remains a major concern in insulin therapy Key risk factors to keep in mind Clinical signs or patient-reported symptoms Prevention strategies Importance of patient education Balancing glycemic targets with hypoglycemia risk Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust. Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

    Preventing & Managing Hypoglycemia
See All (78)

Trailers

About

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

Information

You Might Also Like